======= CYP4A22 ======= == Gene Information == * **Official Symbol**: CYP4A22 * **Official Name**: cytochrome P450 family 4 subfamily A member 22 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=284541|284541]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q5TCH4|Q5TCH4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CYP4A22&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CYP4A22|Open PubMed]] * **OMIM**: [[https://omim.org/entry/615341|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This gene is part of a cluster of cytochrome P450 genes on chromosome 1p33. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2015]. * **UniProt Summary**: Catalyzes the omega- and (omega-1)-hydroxylation of various fatty acids such as laurate and palmitate. Shows no activity towards arachidonic acid and prostaglandin A1. Lacks functional activity in the kidney and does not contribute to renal 20-hydroxyeicosatetraenoic acid (20-HETE) biosynthesis. {ECO:0000269|PubMed:10860550, ECO:0000269|PubMed:15611369}. |p450| |laurate hydroxylase activity| |16-hydroxypalmitate dehydrogenase activity| |arachidonic acid omega-hydroxylase activity| |lipid hydroxylation| |omega-hydroxylase P450 pathway| |arachidonic acid metabolic process| |unsaturated fatty acid metabolic process| |icosanoid metabolic process| |long-chain fatty acid metabolic process| |iron ion binding| |heme binding| |fatty acid derivative metabolic process| |lipid modification| |fatty acid metabolic process| |monocarboxylic acid metabolic process| |carboxylic acid metabolic process| |endoplasmic reticulum membrane| |cellular lipid metabolic process| |oxidation-reduction process| |oxoacid metabolic process| |organic acid metabolic process| |lipid metabolic process| |extracellular space| |small molecule metabolic process| \\ === CRISPR Data === No hits were found. ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.443| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13261 * **Expression level (log2 read counts)**: 0.56 {{:chemogenomics:nalm6 dist.png?nolink |}}